Skip to main content
Premium Trial:

Request an Annual Quote

Celera Registers Shares with Nasdaq on Eve of Split with ABI

NEW YORK (GenomeWeb News) – Celera, which is scheduled to officially split tomorrow from parent firm Applera and sister company Applied Biosystems, has registered to have its shares float on the Nasdaq Stock Market.
 
The firm’s shares currently trade as a tracking stock of Applera on the New York Stock Exchange. Its stock will be delisted from the New York Stock Exchange when the split is finalized.
 
Celera had initially filed for the split in April. Under terms of the separation, shareholders of the Applera Group-Celera Group tracking stock will receive one share of new Celera Corporation shares for each share of the tracking stock they currently own. Upon completion of the deal, Celera will become an independent, publicly traded company.
 
 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.